Haemonetics Corp. buy Citigroup Inc.
Start price
09.07.25
/
50%
€65.00
Target price
09.07.26
€76.78
Performance (%)
-36.31%
Price
10.10.25
€41.00
Summary
This prediction is currently active. Massive losses of -36.31% have been the result for the BUY prediction by Citigroup_Inc_. This prediction currently runs until 09.07.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 1.435% | 1.435% |
| iShares Core DAX® | -0.693% | 2.143% |
| iShares Nasdaq 100 | -1.173% | 1.632% |
| iShares Nikkei 225® | -1.388% | 2.138% |
| iShares S&P 500 | -1.411% | 0.648% |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€41.40
07.10.25
07.10.25
€54.71
07.10.26
07.10.26
-0.97%
10.10.25
10.10.25
